2021 annual financial data
Mereo BioPharma Group 2021 Net margin
Mereo BioPharma Group 2021 net margin with verified reported values.
Direct answer
Net margin was 34.9%.
Operating income was -28,255,999.14 GBP and net income was 17,174,130 GBP.
Operating cash flow was -7,070,747.97 GBP.
Get free Mereo BioPharma Group email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 49,213,161 GBP
- Operating income
- -28,255,999.14 GBP
- Net income
- 17,174,130 GBP
- Operating cash flow
- -7,070,747.97 GBP
Explore related company data
View all 2021 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Mereo BioPharma Group financial years